Search Results 1851-1860 of 19985 for Receptor
In one study, she is investigating a series of biomarkers related to the initial treatment for patients with estrogen receptor-positive (ER+) breast cancer ...
... receptors (e.g, tegaserod, ondansetron, tropisetron, granisetron, dolasetron, mirtazapine);; All narcotics (e.g, codeine, morphine, and propoxyphene, either ...
Treatment with endothelin receptor antagonists (ERAs), phosphodiesterase-5 (PDE5) inhibitors, intravenous (i.v)., subcutaneous (s.c.), or oral prostanoids ...
T-cell receptor diversity may be key to treatment of follicular lymphoma, Mayo study. Cancer. T-cell receptor diversity may be key to treatment of ...
... receptor-T cell therapy featured image. Biotherapeutics. Science Saturday: Addressing the challenges of chimeric antigen receptor-T cell therapy. Marla ...
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to ...
T-cell receptor diversity may be key to treatment of follicular lymphoma, Mayo study finds. Joe Dangor. February 19, 2019.
The purpose of this study is tol compare the effect of retreatment with 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) to the usual ...
Learn about the symptoms, causes and treatment of this immune system condition that results in too much thyroid hormone.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.